🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fara Brasó‐Maristany

Target (United States)

ORCID: 0000-0001-5440-9643

Also affiliated with Breast Cancer Research Foundation, Center for Cancer and Blood Disorders, Hospital Clínic de Barcelona, Center for Cancers and Blood Disorders, Colorado Blood Cancer Institute, Biomedical Research Institute, Oryzon Genomics (Spain), Fundació Clínic per a la Recerca Biomèdica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation”.

A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

The Lancet Oncology(2020)10.1016/s1470-2045(20)30450-2
N/A
0DataRank · unranked
75 citations

Valentina Guarneri, Laia Paré, Gaia Griguolo, Tomás Pascual, Maria Vittoria Dieci +34 more

Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3324
N/A
0DataRank · unranked
41 citations

Marta Palafox, Laia Monserrat, Fara Brasó‐Maristany, Andreu Òdena, Mònica Sánchez-Guixé +26 more

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

Research Square(2021)10.21203/rs.3.rs-236645/v1
N/A
0DataRank · unranked
12 citations

Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Abel González-Pérez, Mafalda Oliveira +33 more

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

Nature Communications(2022)10.1038/s41467-022-32828-6
N/A
0DataRank · unranked
121 citations

Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Abel González-Pérez, Mafalda Oliveira +33 more

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)

ESMO Open(2024)10.1016/j.esmoop.2024.102388
N/A
0DataRank · unranked
18 citations

Tomás Pascual, Fara Brasó‐Maristany, Laia Paré, Olga Martínez‐Sáez, Javier Cortés +15 more

ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27

Nature Communications(2025)10.1038/s41467-025-59184-5
N/A
0DataRank · unranked
10 citations

Yijie Wang, Lei Bao, Gonçalo Vale, Jeffrey G. McDonald, Yisheng Fang +9 more

Stromal tumor infiltrating lymphocytes and TNBC-DX provide complementary prognostic information in triple-negative breast cancer

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf162
N/A
0DataRank · unranked
1 citations

Miguel Martín, Guillermo Villacampa, Marı́a del Monte-Millán, Rachel Yoder, Harsh B. Pathak +23 more

Figure S4 from A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor–positive HER2-negative Breast Cancer

10.1158/1078-0432.22477253
N/A
0DataRank · unranked
0 citations

Yi-Hsuan Tsai, Tomás Pascual, Laia Paré, Barbara Adamo, María Vidal +8 more